Diagnostic Testing for Pulmonary Vascular Disease. Invasive Testing

Unilateral absence of the pulmonary veins: an unusual diagnosis with characteristic imaging findings

Terry L. Levin, Bradford W. Betz, Lisa M. Gennarini, Chana WircbergChildren’s Hospital of Montefiore Medical Center.United States Clinical ImagingClin Imaging 2019; 55:107-111DOI: 10.1016/j.clinimag.2019.01.022 AbstractBackground: Congenital unilateral absence of the pulmonary vein (UCAPV) is a rare entity with characteristic clinical and imaging findings. Despite its congenital nature, the radiographic findings and symptoms of UCAPV may not be recognized […]

Unilateral absence of the pulmonary veins: an unusual diagnosis with characteristic imaging findings Read More »

A 12-Year-Old Girl With Dyspnea and Unilateral Interlobular Septal Thickening

Yong Chen, Yao Xiao, Ying Zhang, Guangfa Zhu, Ruiyu Dou, Hong GuBeijing Anzhen Hospital and Capital Medical University.China ChestChest 2019; 156: e57-e61DOI: 10.1016/j.chest.2019.03.022 AbstractA 12-year-old girl was admitted to the hospital for exercise intolerance and radiographic abnormalities. She presented with a 5-year history of shortness of breath during intense exercise and did not undergo any medical

A 12-Year-Old Girl With Dyspnea and Unilateral Interlobular Septal Thickening Read More »

Diagnosis and management of congenital right pulmonary venous atresia

I. Ricardo Argueta-morales, Ruchira Garg, William M. DeCampliMiami Children’s Hospital and Arnold Palmer Hospital for Children.United States Cardiology in the YoungCardiol Young 2009; 19: 648-651DOI: 10.1017/S1047951109991867 AbstractCongenital unilateral pulmonary venous atresia is a rare anatomical defect. Patients present with pulmonary symptoms, and diagnosis may be elusive. Pulmonary arterial wedge angiography is the gold standard with which

Diagnosis and management of congenital right pulmonary venous atresia Read More »

Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow-up of 86 patients

Gabriel F. Diaz, Carlos E. Diaz‐Castrillon, Alicia Marquez Garcia, Rachel K. Hopper, Vinicio de J. PerezUniversidad Nacional De Colombia. University of Pittsburgh. Centro Policlínico Del Olaya and Clínica De La Mujer. Stanford University School of Medicine. Columbia and United States Pulmonary CirculationPulm Circ 2025; 15: DOI: 10.1002/pul2.70017 AbstractPulmonary hypertension (PH) at high altitudes presents unique characteristics

Importance of age at diagnosis of pulmonary hypertension in children living at high altitude: Longitudinal follow-up of 86 patients Read More »

Unusual Pulmonary Manifestation in a Child With Congenital Mitral Stenosis: A Case Report

Ola Alhalabi, Ahmed Abushahin, Atqah AbdulwahabSidra Medicine.Qatar CureusCureus 2025; 17: DOI: 10.7759/cureus.80575 AbstractCongenital mitral valve stenosis (MVS) in children is usually isolated. However, it is, in rare cases, associated with secondary pulmonary hemosiderosis. It is hypothesized that secondary pulmonary hemosiderosis results from chronic pulmonary venous congestion and repeated microvascular hemorrhage due to elevated left atrial pressure.

Unusual Pulmonary Manifestation in a Child With Congenital Mitral Stenosis: A Case Report Read More »

Virtual reality modelling based on computed tomography and three-dimensional angiography for planning of percutaneous and hybrid treatment in infants with pulmonary vein stenosis

Judyta Szeliga, Małgorzata Waśko, Jacek Kołcz, Andrzej Rudziński, Ryan Callahan, Sebastian GórecznyUniversity Children’s Hospital and Jagiellonian University Medical College. Children’s Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania.Poland and United States Advances in Interventional CardiologyAdv Interv Cardiol (Postepy Kardiol Interwencyjnej) 2025; 21: 108-113DOI: 10.5114/aic.2025.147992 AbstractAbstract Not Available CategorySegmental Pulmonary Venous Disease.

Virtual reality modelling based on computed tomography and three-dimensional angiography for planning of percutaneous and hybrid treatment in infants with pulmonary vein stenosis Read More »

High Altitude May Protect Against the Early Development of Irreversible Pulmonary Hypertension in Patients With Congenital Heart Disease

Inge von Alvensleben, Brian B. Graham, Gustavo A. Balanza, Carlos Brockmann, Ericka C. Pérez, Ximena Y. Vicente, Carla Arteaga, Claudia Scherer, Franz P. Freudenthal, Rubin M. Tuder, Alexandra HeathKardiozentrum. University of Colorado. University of California San Francisco. Massachusetts General Hospital and Harvard Medical School. Hospital Belga.Bolivia and United States Pulmonary CirculationPulm Circ 2025; 15:  DOI: 10.1002/pul2.70049

High Altitude May Protect Against the Early Development of Irreversible Pulmonary Hypertension in Patients With Congenital Heart Disease Read More »

Follow-up of transcatheter closure of congenital heart disease complicated with pulmonary arterial hypertension in children

Yanyun Huang, Yuting Chen, Danyan Su, Suyuan Qin, Cheng Chen, Dongli Liu, Bingbing Ye, Yuqin Huang, Piaoliu Yuan, Yusheng PangFirst Affiliated Hospital of Guangxi Medical University. China Frontiers in PediatricsFront Pediatr 2025; 13: DOI: 10.3389/fped.2025.1562782 AbstractBackground: Transcatheter closure is now the preferred treatment for congenital heart disease complicated with pulmonary arterial hypertension (CHD-PAH), but its long-term effects

Follow-up of transcatheter closure of congenital heart disease complicated with pulmonary arterial hypertension in children Read More »

Long-term survival of shunt closure in atrial septal defects with pulmonary arterial hypertension

Wenjie Chen, Jingyuan Chen, Min Peng, Jun Luo, Haihua Qiu, Yusi Chen, Jiang LiSecond Xiangya Hospital of Central South University. China International Journal of CardiologyInt J Cardiol 2025; DOI: 10.1016/j.ijcard.2025.133094 AbstractObjective: This study aims to refine closure indications and assess long-term outcomes in pulmonary arterial hypertension associated with atrial septal defect (PAH-ASD).Methods: We enrolled 197 PAH-ASD patients classified

Long-term survival of shunt closure in atrial septal defects with pulmonary arterial hypertension Read More »

Inhalation of the Novel Tryptophan Hydroxylase 1 Inhibitor TPT-004 Alleviates Pulmonary Arterial Hypertension in Rats

Ekaterina Legchenko, Philippe Chouvarine, Klea Hysko, Fatimunnisa Qadri, Radoslw Wesolowski, Edgar Specker, Silke Glage, Martin Meier, Katharina Schwarz, Joerg Heineke, Gerhard Pohlmann, Mehmet Ramazanoglu, Michael Bader, Georg HansmannHannover Medical School. Heidelberg University Medical Faculty Mannheim. Max-Delbrück-Center for Molecular Medicine. Leibniz-Forschungsinstitut für Molekulare Pharmakologie. Fraunhofer Institute for Toxicology and Experimental Medicine. Max Delbrück Center for Molecular

Inhalation of the Novel Tryptophan Hydroxylase 1 Inhibitor TPT-004 Alleviates Pulmonary Arterial Hypertension in Rats Read More »

Scroll to Top